High Prevalence of Bone Cancer and Development and Approval of Novel Therapies to Augment Growth of Bone Cancer Treatment Market



The exact cause of bone tumors is not known. They tend to occur in places of the bone, which grow very rapidly. Possible causes are genetics passed down in families, malnutrition, and radiation therapy to cancer patients. In some cases, the cancer cells become resistant to treatment, which leads to malignant melanoma. Treatment of melanoma usually involves either surgery to remove the growth or radiotherapy.

Cancer of the bone marrow is relatively rare but does happen. This condition occurs when a malignant melanoma grows in the bone marrow which can then spread to other parts of your body. Common symptoms include shivering, shortness of breath, palpitations, fever, abdominal pain, nausea, vomiting, fatigue, frequent urination, nausea, and weight loss. You should call your doctor immediately if you experience any of these symptoms. It is possible for cancer to spread to other parts of your body.

Market Dynamics

The high prevalence of bone cancer is expected to propel the growth of the bone cancer treatment market. For instance, according to The American Cancer Society’s estimates for cancer of the bones and joints for 2020, about 3,600 new cases will be diagnosed and about 1,720 deaths from these cancers are expected, in the U.S. 

Approval and launch of new products are also expected to aid in the growth of the bone cancer treatment market. For instance, in October 2020, Oncternal Therapeutics, a clinical-stage oncology company, received Rare Pediatric Disease Designation from the U.S. FDA for its TK216, a targeted small-molecule inhibitor of the E26 transformation-specific family of oncoproteins including fusion proteins, for the treatment of Ewing sarcoma, an ultra-rare cancerous tumor that grows in the bones or soft tissue around bones. Similarly, in August 2020, Celgene International announced that the company’s Revlimid – or lenalidomide, a pill that doubles survival rates for people with myeloma, received approval for use in the European Union.

Competitive Analysis 

Major players operating in the bone cancer treatment market include Amgen Inc., Actavis plc, Novartis International AG, Debiopharm Group, Oncternal Therapeutics, Pfizer, Inc., Celgene International, BeiGene, and Eli Lilly and Company.

Major players operating in the bone cancer treatment market are focused on the approval and launch of new products to expand their product portfolio. For instance, in December 2020, BeiGene, a biopharmaceutical company, announced that its BLINCYTO (blinatumomab) for injection was approved in China for the treatment of adult patients with relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukemia (ALL) and bone marrow cancer.

Comments

Post a Comment

Popular posts from this blog

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Image
  Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome. Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vaccines
Read more

Increasing Geriatric Population Is Driving the Growth of the Sexual Health Market

Image
       Sexual health is an important part of a person’s physical and mental health. According to the World Health Organization (WHO), sexual health requires a respectful and positive approach to sexual relationships and sexuality, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, violence, and discrimination. Sexual health leads to a healthy sex life without any sexually transmitted diseases, and to take preventive measures to avoid sexually transmitted infections. The elderly population (geriatric population) often suffer from one or more sexual disorders, such as premature (early) ejaculation, erectile dysfunctions, dyspareunia, and hypoactive sexual desire disorder, among others. Thus, with the increasing geriatric population worldwide, the prevalence/incidence of sexual disorders is also increasing, driving the growth of the sexual health market . According to WHO, the world's population aged 60 years and older is expected to tota
Read more